Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy
Authors
Keywords
Chronic kidney disease, Diabetes, Diabetic nephropathy, Nephrology, Renoprotection, Serum uric acid, Sodium glucose co-transporter 2 (SGLT 2) inhibitors
Journal
ADVANCES IN THERAPY
Volume 32, Issue 12, Pages 1177-1191
Publisher
Springer Nature
Online
2015-12-10
DOI
10.1007/s12325-015-0272-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Relationship Between Uric Acid, Allopurinol, Cardiovascular Events, and Kidney Disease Progression: A Step Forward
- (2015) Gianni Bellomo AMERICAN JOURNAL OF KIDNEY DISEASES
- Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
- (2015) Marian Goicoechea et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study
- (2015) K. I. Greenberg et al. Clinical Journal of the American Society of Nephrology
- Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
- (2015) Andrzej S. Krolewski DIABETES CARE
- Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus
- (2015) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes
- (2015) B. Bode et al. DIABETES OBESITY & METABOLISM
- Fructose and uric acid in diabetic nephropathy
- (2015) Petter Bjornstad et al. DIABETOLOGIA
- Hyperuricemia is associated with progression of IgA nephropathy
- (2015) Ali Bakan et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- High Uric Acid Levels During Pregnancy Linked to Increased Risk for Future Atherosclerotic-Related Hospitalization
- (2015) Talya Wolak et al. Journal of Clinical Hypertension
- Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
- (2015) Mark E. Molitch et al. KIDNEY INTERNATIONAL
- No development of hypertension in the hyperuricemic liver-Glut9 knockout mouse
- (2015) Frederic Preitner et al. KIDNEY INTERNATIONAL
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Uric Acid Is Independently Associated with Diabetic Kidney Disease: A Cross-Sectional Study in a Chinese Population
- (2015) Dandan Yan et al. PLoS One
- Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
- (2014) Hala Yamout et al. AMERICAN JOURNAL OF NEPHROLOGY
- SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
- (2014) Yukihiro Chino et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
- (2014) Tatsuo Hosoya et al. Clinical and Experimental Nephrology
- Association of a Polymorphism in a Gene Encoding a Urate Transporter with CKD Progression
- (2014) A. Testa et al. Clinical Journal of the American Society of Nephrology
- Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
- (2014) Lawrence A. Leiter et al. DIABETES CARE
- Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
- (2014) Hans-Ulrich Häring et al. DIABETES CARE
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells
- (2014) Toru Kimura et al. PLoS One
- Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results
- (2014) Keith Usiskin et al. POSTGRADUATE MEDICINE
- The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study
- (2014) Tatsuo Hosoya et al. Trials
- Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy
- (2014) Jingjing Zhou et al. BMC Nephrology
- Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
- (2014) Ling Li et al. BMC Nephrology
- Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
- (2014) Anthony H Barnett et al. Lancet Diabetes & Endocrinology
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up
- (2013) Gen-yang Cheng et al. CLINICAL NEPHROLOGY
- Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
- (2013) David M. Maahs et al. Current Diabetes Reports
- Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal?
- (2013) Zohreh Soltani et al. CURRENT HYPERTENSION REPORTS
- Urate transporters in the genomic era
- (2013) Hiroyuki Sakurai CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
- (2013) R. J. Johnson et al. DIABETES
- Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin: An active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes
- (2013) E. Ferrannini et al. DIABETES CARE
- Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
- (2013) Donald E. Kohan et al. KIDNEY INTERNATIONAL
- Uric acid and chronic kidney disease: which is chasing which?
- (2013) R. J. Johnson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis
- (2013) Yili Xu et al. PLoS One
- Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
- (2012) Ion Alexandru Bobulescu et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
- (2012) K. Stenlöf et al. DIABETES OBESITY & METABOLISM
- An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study
- (2012) Kentaro Kohagura et al. HYPERTENSION RESEARCH
- SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
- (2012) Ele Ferrannini et al. Nature Reviews Endocrinology
- Notice
- (2012) Kidney International Supplements
- Uric Acid Levels Predict Future Development of Chronic Kidney Disease
- (2011) Hiroo Sonoda et al. AMERICAN JOURNAL OF NEPHROLOGY
- A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
- (2011) Giovanni Musso et al. ANNALS OF MEDICINE
- Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies
- (2011) Naohiko Anzai et al. Clinical and Experimental Nephrology
- Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
- (2011) G. Zoppini et al. DIABETES CARE
- The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia
- (2011) R. A. DeFronzo et al. DIABETES OBESITY & METABOLISM
- Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment
- (2011) Yan Miao et al. HYPERTENSION
- Serum Uric Acid as a New Player in the Development of Diabetic Nephropathy
- (2011) Peter Hovind et al. JOURNAL OF RENAL NUTRITION
- Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial
- (2011) Yongjun Shi et al. KIDNEY & BLOOD PRESSURE RESEARCH
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
- (2011) William G. Couser et al. KIDNEY INTERNATIONAL
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study
- (2011) Christina Voulgari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus
- (2011) Hiroyuki Ito et al. PLoS One
- Uric Acid as a Mediator of Diabetic Nephropathy
- (2011) Diana I. Jalal et al. SEMINARS IN NEPHROLOGY
- Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem
- (2011) Duk-Hee Kang et al. SEMINARS IN NEPHROLOGY
- Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
- (2010) Gianni Bellomo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up
- (2010) L. H. Ficociello et al. DIABETES CARE
- Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes study
- (2010) D. I. Jalal et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Uric Acid and Long-term Outcomes in CKD
- (2009) Magdalena Madero et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2009) Helen M. Colhoun et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Risk Factors for End-Stage Renal Disease
- (2009) Chi-yuan Hsu et al. ARCHIVES OF INTERNAL MEDICINE
- Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study
- (2009) P. Hovind et al. DIABETES
- Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy
- (2009) F. Preitner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia
- (2008) Hirotaka Matsuo et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT 1) in Hypertensive Patients
- (2008) T. Hamada et al. AMERICAN JOURNAL OF HYPERTENSION
- High-Normal Serum Uric Acid Is Associated with Impaired Glomerular Filtration Rate in Nonproteinuric Patients with Type 1 Diabetes
- (2008) E. T. Rosolowsky et al. Clinical Journal of the American Society of Nephrology
- Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study
- (2008) Gisela Sturm et al. EXPERIMENTAL GERONTOLOGY
- Uric Acid and Incident Kidney Disease in the Community
- (2008) D. E. Weiner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Elevated Uric Acid Increases the Risk for Kidney Disease
- (2008) R. P. Obermayr et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- SLC2A9 Is a High-Capacity Urate Transporter in Humans
- (2008) Mark J Caulfield et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started